IO Biotech Inc. (IOBT)

AI Score

Unlock

0.93

-0.01 (-1.06%)

At close: Apr 24, 2025, 3:58 PM

0.95

2.95%

After-hours: Apr 24, 2025, 06:57 PM EDT

IO Biotech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	60.03M	80.19M	100.75M	117.98M	143.19M	165.5M	110.09M	128.53M	142.59M	151.17M	170.12M	187.9M	211.53M	45.48M	54.75M	-3.4M	3.4M	-7.85M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	6.81M	n/a	15.69M
Long-Term Investments	n/a	n/a	n/a	268K	268K	268K	268K	268K	268K	n/a	268K	268K	268K	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	385K	1.19M	1.14M	883K	89K	867K	891K	876K	84K	1.15M	910K	136K	127K	45K	38K	-3.4M	18K	-7.85M
Receivables	1.13M	964K	1.03M	909K	1.13M	954K	1.2M	1.01M	1.53M	1.09M	2.07M	2.79M	2.09M	2.12M	n/a	n/a	1.5M	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	-954K	929K	1.73M	-1.53M	5.18M	6.57M	8.27M	-2.09M	4.04M	217K	n/a	359K	n/a
Other Current Assets	1.92M	933K	774K	911K	754K	680K	814K	1.01M	685K	313K	201K	281K	149K	2.77M	3.74M	n/a	371K	n/a
Total Current Assets	64.95M	86.24M	107.65M	124.13M	147.25M	168.25M	113.04M	132.27M	148.22M	157.75M	178.96M	199.25M	221.74M	51.99M	58.5M	3.4M	5.63M	7.85M
Property-Plant & Equipment	2.36M	2.51M	2.67M	2.88M	3.11M	3.16M	3.36M	3.43M	3.23M	3.25M	2.51M	2.52M	155K	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.75M	3.7M	3.81M	4.03M	3.46M	4.3M	4.52M	4.58M	3.59M	4.41M	3.68M	2.92M	550K	45K	38K	-3.4M	18K	-7.85M
Total Assets	67.7M	89.94M	111.47M	128.16M	150.72M	172.55M	117.56M	136.84M	151.81M	162.16M	182.65M	202.17M	222.29M	52.04M	58.53M	n/a	5.65M	n/a
Account Payables	4.66M	5.26M	5.02M	3.84M	3.88M	6.64M	4.46M	4.26M	4M	2.35M	4.54M	2.09M	3.93M	2.17M	1.7M	n/a	522K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	4.83M	n/a	n/a	3.04M	n/a	n/a	n/a	-28.28M	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	678K	n/a	655K	627K	613K	559K	515K	492K	419K	345K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	5.04M	4.93M	4.83M	5M	6.3M	2.49M	2.25M	3.72M	3.78M	1.55M	1.93M	3.03M	461K	29.16M	32.77M	n/a	1.74M	n/a
Total Current Liabilities	19.49M	16.05M	13.72M	11.04M	15.72M	12.98M	10.88M	10.36M	10.68M	6.32M	8.55M	6.43M	10.3M	33.79M	38.95M	n/a	3.05M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	59K	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	1.2M	1.32M	1.47M	1.65M	1.84M	1.98M	2.16M	2.27M	2.27M	2.35M	1.92M	2.05M	59K	37.91M	37.91M	n/a	37.91M	n/a
Total Liabilities	20.68M	17.38M	15.2M	12.69M	17.56M	14.96M	13.04M	12.63M	12.95M	8.67M	10.47M	8.48M	10.36M	71.69M	76.86M	n/a	40.96M	n/a
Total Debt	1.92M	2.02M	2.15M	2.32M	2.49M	2.6M	2.77M	2.83M	2.79M	2.84M	2.34M	2.39M	n/a	28.28M	n/a	n/a	n/a	n/a
Common Stock	66K	66K	66K	66K	66K	66K	29K	29K	29K	29K	29K	29K	29K	28K	28K	n/a	28K	n/a
Retained Earnings	-359.31M	-327.98M	-303.96M	-283.28M	-263.82M	-237.64M	-215.96M	-194.78M	-177.74M	-157.67M	-141.98M	-123.48M	-106.28M	-84.97M	-83.88M	n/a	-38.4M	n/a
Comprehensive Income	-6.85M	-11M	-9.63M	-9.47M	-9.67M	-9.87M	-9.77M	-9.62M	-10.14M	-13.92M	-8.52M	-4.14M	-1.49M	705K	1.42M	-35.3M	1.96M	-23.53M
Shareholders Equity	47.02M	72.56M	96.27M	115.47M	133.16M	157.59M	104.52M	124.22M	138.85M	153.49M	172.18M	193.69M	211.92M	-19.65M	-18.33M	2.6M	-35.3M	-1.47M
Total Investments	n/a	n/a	268K	268K	268K	268K	268K	268K	268K	n/a	268K	268K	268K	n/a	n/a	6.81M	n/a	15.69M